β2-M may accelerate human renal cell carcinoma cell growth via activation of PI3K/Akt and ERK, and induce phosphorylation of the Bcl-xL/Bcl-2-associated death promoter (Bad). Here, B2M is linked to hereditary clear cell renal cell carcinoma.